Zhejiang Tianyu Pharmaceutical Co. Ltd. – FDA 483, Nov 21, 2024
An FDA inspection of Zhejiang Tianyu Pharmaceutical Co., Ltd. in Huangyan, China, an API manufacturer, revealed significant deficiencies in quality control and equipment cleaning. The firm failed to establish proper impurity profiles for identified and unidentified impurities in recovered materials and intermediates, and also lacked appropriate cleaning schedules for storage tanks, leading to potential contamination risks. These issues indicate a lack of robust quality systems for API manufacturing.
ID · 1a60a15b-bf58-4a25-b4f2-51d949d8d3f9
Comes with the profile
KRA (KeyPedia Risk Analysis)
How likely the FDA is to take enforcement action in the next 12 months.
Example18-month trend
Form 483 · November 21, 2024
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Zhejiang Tianyu Pharmaceutical Co. Ltd. document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA